D
Esperion Therapeutics, Inc. ESPR
$1.50 $0.000.00%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue 69.11M 51.63M 73.83M 137.74M 32.25M
Total Other Revenue -- -- -- -- --
Total Revenue 69.11M 51.63M 73.83M 137.74M 32.25M
Cost of Revenue 36.61M 27.68M 27.07M 23.48M 29.19M
Gross Profit 32.51M 23.95M 46.76M 114.26M 3.06M
SG&A Expenses 36.93M 39.98M 44.19M 41.99M 45.42M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 73.53M 67.66M 71.26M 65.47M 74.62M
Operating Income -4.42M -16.03M 2.58M 72.27M -42.37M
Income Before Tax -21.32M -29.52M -61.93M 61.02M -56.34M
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -21.32M -29.52M -61.93M 61.02M -56.34M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -21.32M -29.52M -61.93M 61.02M -56.34M
EBIT -4.42M -16.03M 2.58M 72.27M -42.37M
EBITDA -4.39M -16.00M 2.58M 72.31M -42.36M
EPS Basic -0.11 -0.15 -0.33 0.36 -0.50
Normalized Basic EPS -0.06 -0.09 -0.03 0.23 -0.31
EPS Diluted -0.11 -0.15 -0.33 0.34 -0.50
Normalized Diluted EPS -0.06 -0.09 -0.03 0.20 -0.31
Average Basic Shares Outstanding 195.57M 194.93M 188.79M 169.26M 112.40M
Average Diluted Shares Outstanding 195.57M 194.93M 188.79M 189.64M 112.40M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings